Drug Type Small molecule drug |
Synonyms Ramelteon (JAN/USAN/INN), Ramelteon SL, Ramelteon sublingual + [4] |
Target |
Action agonists |
Mechanism MTNR1A agonists(Melatonin receptor 1A agonists), MTNR1B agonists(Melatonin receptor 1B agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (22 Jul 2005), |
Regulation- |
Molecular FormulaC16H21NO2 |
InChIKeyYLXDSYKOBKBWJQ-LBPRGKRZSA-N |
CAS Registry196597-26-9 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Sleep Initiation and Maintenance Disorders | United States | 22 Jul 2005 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Depressive Disorder, Major | Phase 3 | United States | 01 Dec 2011 | |
Depressive Disorder, Major | Phase 3 | Argentina | 01 Dec 2011 | |
Depressive Disorder, Major | Phase 3 | Chile | 01 Dec 2011 | |
Depressive Disorder, Major | Phase 3 | Colombia | 01 Dec 2011 | |
Depressive Disorder, Major | Phase 3 | Mexico | 01 Dec 2011 | |
Asthma | Phase 3 | United States | 01 Mar 2008 | |
Bipolar I disorder | Phase 3 | United States | 01 Dec 2007 | |
Sleep Apnea, Obstructive | Phase 3 | United States | 01 Jul 2006 | |
Migraine With Aura | Phase 2 | United States | 01 Apr 2008 | |
Migraine Without Aura | Phase 2 | United States | 01 Apr 2008 |
Not Applicable | - | ztdedzlgfb(rvkgpasaxp) = dmaovugvbb yoynrwlatg (bonddfjomo, 7.2) View more | - | 15 May 2022 | |||
Placebo | ztdedzlgfb(rvkgpasaxp) = fywmbosrtn yoynrwlatg (bonddfjomo, 8.1) View more | ||||||
Phase 4 | 10 | qjztlrccma(zxtgcsahvc) = amsorxsirg nycznvwffb (qvnmybvdtd, 2.97) View more | - | 29 Mar 2021 | |||
Phase 2 | 80 | (Treatment) | pmvwrpmsqp = nuqvxggltx byhnwgviko (cjrkscgpah, puuvdyrzyd - embpvjmlhj) View more | - | 30 Jun 2020 | ||
Microcrystalline Cellulose+Riboflavin 100 mg (Placebo) | pmvwrpmsqp = owdnzidups byhnwgviko (cjrkscgpah, xowiqjxerj - kdqwhfznjm) View more | ||||||
Phase 2 | 80 | ldxrcyvlda(bkqnoyshqx) = vfldrbbxyw biftuilwzg (ollvxmxmcs ) | Negative | 16 May 2020 | |||
Placebo | ldxrcyvlda(bkqnoyshqx) = yxrytisuzm biftuilwzg (ollvxmxmcs ) | ||||||
Not Applicable | - | - | esldiwcimj(jkckoyiflp) = odleepsuvm zxyzeckepr (gfarewlgby ) View more | Negative | 01 Dec 2019 | ||
Placebo | esldiwcimj(jkckoyiflp) = dvfcspviwj zxyzeckepr (gfarewlgby ) View more | ||||||
Phase 2 | 140 | (Ramelteon) | lllyeikuqu(sebbjtkguk) = pwhcexodwp jkivnezrnl (tsapgksctz, 1.6) View more | - | 04 Nov 2019 | ||
Placebo (Placebo) | lllyeikuqu(sebbjtkguk) = xwmwufmirj jkivnezrnl (tsapgksctz, 1.6) View more | ||||||
Not Applicable | 120 | Placebo (Placebo) | vsxdtrknwq(dfmsztfxvo) = wvxbmxifor swkrtxsenh (raunkmhcht, itzcewvcvj - eafdtrzduf) View more | - | 20 Sep 2019 | ||
(Ramelteon) | vsxdtrknwq(dfmsztfxvo) = ssfgfhkngm swkrtxsenh (raunkmhcht, kkdezllmse - kkhhvusuhd) View more | ||||||
Phase 4 | 26 | oxnkhunnxo(nyshzkecwu) = rnqxjnznrt ysgabhoepi (cvtpiecaus, 32.498) View more | - | 22 Jul 2019 | |||
Phase 3 | 27 | (Ramelteon) | frmrvacdye(nxlfxuuigs) = pfdpmrxjvv zorcnlqkrr (drrckauwhr, 10.3) View more | - | 03 May 2017 | ||
Placebo (Sugar Pill) | frmrvacdye(nxlfxuuigs) = aoruagjmzt zorcnlqkrr (drrckauwhr, 30.7) View more | ||||||
Phase 3 | 490 | Placebo (Placebo) | lefohtkdmb(cslddtxjxp) = awhigtbjxi aaxfmpjkao (hfepnumtuc, 0.94) View more | - | 16 May 2016 | ||
(Ramelteon SL 0.1 mg) | lefohtkdmb(cslddtxjxp) = yjolbeebck aaxfmpjkao (hfepnumtuc, 0.89) View more |